Chapter 4. Central Nervous System - GMMMG

Rufinamide (Inovelon® ) in the treatment of seizures ...

NOT TO BE USED FOR COMMERCIAL OR MARKETING PURPOSES Date of original recommendation: 22nd June 2010 Date Re-reviewed: 21st October 2014 Rufinamide (Inovelon® ) in the treatment of seizures

FreeStyle Libre Flash Glucose Monitoring System.

NOT TO BE USED FOR COMMERCIAL OR MARKETING PURPOSES November 2017 FreeStyle Libre Flash Glucose Monitoring System. The Formulary and Managed Entry Subgroup discussed the above at its

  System, Monitoring, Flash, Glucose, Libre, Freestyle, Freestyle libre flash glucose monitoring system

NTS recommendation Brimonidine gel for acne …

NOT TO BE USED FOR COMMERCIAL OR MARKETING PURPOSES 17th June 2014 Brimonidine (Mirvaso® ) gel for the treatment of acne rosacea erythema. The New Therapies Subgroup (NTS) discussed the above drug at a

  Brimonidine, Brimonidine gel

Tapentadol (Palexia®) prolonged and immediate …

November 2015 Tapentadol (Palexia®) prolonged and immediate release tablets for the treatment of acute and chronic severe pain. The New Therapies Subgroup of the Greater Manchester Medicines

  Release, Tablets, Immediate, Prolonged, Tapentadol, Prolonged and immediate release tablets

Hydrocortisone modified release tablet …

NOT TO BE USED FOR COMMERCIAL OR MARKETING PURPOSES 17th April 2014 Hydrocortisone modified release tablet (Plenadren®) for the treatment of adrenal …

  Adrenal

Low Strength Antipsychotic Prescribing in Dementia: A GP ...

GMMMG – championing the appropriate use of medicines across Greater Manchester PAGE | 4 AIM AIM To aid the primary care review of low strength antipsychotic prescribing in dementia patients.

  Prescribing, Antipsychotic, Dementia, Strength, Low strength antipsychotic prescribing in dementia

GMMMG COPD Formulary Inhaler Options September 2018 ...

GMMMG COPD Formulary Inhaler Options – September 2018 Produced by Regional Drug and Therapeutics Centre (RDTC) for the GMMMG. September 2018 BNF 3.1.2 – Antimuscarinic bronchodilators (LAMA) 1st choice Alternatives Tiotropium Aclidinium Glycopyrronium Umeclidinium

Non-pharmacological management for ALL patients

6 Treatment of new COPD patients FEV 1 Spirometry (measuring FEV 1 and FVC) is needed to make the diagnosis of COPD. FEV 1 can be used to measure worsening or improvement in patients.

  Copd

Cost Comparison Charts - GMMMG

Regional Drug and Therapeutics Centre Cost comparison charts 2 Jul 2019

  Chart, Comparison, Cost, Cost comparison charts

Management of Vitamin D Deficiency, Insufficiency and ...

Patient group Advice ... (for example, they have osteomalacia).2 Routine screening of high risk groups is not indicated. For convenience, paediatric reference ranges and definitions of deficiency used here are the same as for adults as per the NOS guidance.3 Any child who is suspected to be hypocalcaemic secondary

  Patients, Secondary, Osteomalacia

Intubation Drugs - ambonsall.com

Version 2.0 Intubation Drugs 27/02/2012 Neuromuscular Blocking Agents (NMBAs) a.k.a. Muscle Relaxants At the NMJ, ACh molecules released by the arrival of a nerve impulse diffuse across the

Ciprofloxacin - Antimicrobe

1000mg extended release tablets q24h Prostatits: 500mg PO q12h / 400mg IV q12h x 28 days Uncomplicated gonococcal infections: 500mg PO x 1 dose

  Release, Ciprofloxacin

Formulation and Evaluation of Bilayer Tablets of ...

Formulation And Evaluation Of Bilayeer Tablets Of Glimepiride And Metformin Hcl www.iosrjournals.org 39 | Page

  Metformin

PRODUCT INFORMATION NUELIN SR TABLETS - GP2U

iapnuesr11108.doc PRODUCT INFORMATION NUELIN SR TABLETS . COMPOSITION . Nuelin SR contains 200mg, 250mg or 300mg anhydrous theophylline (1,3- dimethyl xanthine,

  Information, Product, Tablets, 200mg, Product information nuelin sr tablets, Nuelin